Portrait of the Global Health Group

 

Short portrait

The Global Health Group Inc. sees itself as a management holding company that supports innovative companies with a ‘hands-on’ approach. The company’s board accompanies and supports all of the Global Health Group Inc. investments. It offers practical knowledge, branch expertise and his international and worldwide contacts to industry, research and development, as well as capital market experts.

The strategic focus lies in finding and developing products with a high level of innovation in the segment of dietary supplements and nutraceuticals for within the healthcare, beauty, and wellness markets.

Company details

Founding year 2017
End of the financial year December 31
Accounting standards IRS
Shares by piece 10.000.000
Shares in US$ 10.000
Nominal value per share (in CHF) 0.001000
Administrative board Marc Wallendorf

Share details

Number of shares 10.000.000
ISIN pending
WKN pending
CFI-Code pending
NASDAQ Code pending
Type of shares Preferred/Common
Original Clearing pending

Company details at stock market launch

Name IPO
Stock exchange NASDAQ
Transparency standard at initial listing pending
Type of transaction IPO
ICB Sector Food and Beverage
Country United States
Trading symbol pending
First day of trading expected 2020
Issuance process Initial public offering
opening price expected 5.00-7.50
Listing sponsor not yet known

Shareholder structure at initial listing

shareholder shares in %
CSC 6.10
AGAG LLC 78.71
Free float 15.19

Important note: This website and the information contained therein do not represent an encouragement or invitation to buy, sell or conduct any other type of trade in securities of the Global Health Group Inc. Not in the United States of America nor in or any other country. Shares of the Global Health Group Inc. are not offered for public purchase.